KindlyMD (NASDAQ:NAKA) Issues Quarterly Earnings Results

KindlyMD (NASDAQ:NAKA) released its earnings results on Thursday. The company reported ($1.40) EPS for the quarter, missing the consensus estimate of ($0.49) by ($0.91), Zacks reports. KindlyMD had a negative return on equity of 63.45% and a negative net margin of 1,067.93%.

KindlyMD Stock Down 7.4%

Shares of KindlyMD stock traded down $0.46 on Thursday, reaching $5.79. The company’s stock had a trading volume of 145,182 shares, compared to its average volume of 197,286. The company has a market capitalization of $106.22 million, a price-to-earnings ratio of -0.16 and a beta of 16.03. The firm’s fifty day simple moving average is $7.98 and its two-hundred day simple moving average is $7.62. KindlyMD has a 52 week low of $3.33 and a 52 week high of $26.00.

Wall Street Analyst Weigh In

Several brokerages have recently weighed in on NAKA. B. Riley Financial raised their price target on KindlyMD from $11.00 to $13.00 and gave the company a “buy” rating in a report on Tuesday, September 22nd. Weiss Ratings reiterated a “sell (d-)” rating on shares of KindlyMD in a research note on Wednesday, November 4th. Finally, TD Cowen increased their price objective on shares of KindlyMD from $1.00 to $17.00 and gave the company a “buy” rating in a research report on Monday, July 27th. Three research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company. According to MarketBeat, KindlyMD currently has a consensus rating of “Moderate Buy” and a consensus price target of $20.00.

Insider Buying and Selling at KindlyMD

In other KindlyMD news, CEO David F. Bailey purchased 32,134 shares of the stock in a transaction dated Wednesday, August 19th. The shares were purchased at an average cost of $5.59 per share, with a total value of $179,629.06. Following the completion of the acquisition, the chief executive officer directly owned 32,134 shares in the company, valued at $179,629.06. This trade represents a ∞ increase in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders acquired a total of 41,904 shares of company stock valued at $235,231 in the last three months. 24.08% of the stock is owned by insiders.

KindlyMD Company Profile

KindlyMD, Inc. is a healthcare company focused on providing integrated care for patients dealing with chronic pain, behavioral health conditions and substance-use disorders. The company emphasizes a patient-centered approach that combines medical treatment, behavioral health support and other services designed to address the underlying factors affecting a patient’s health and quality of life. KindlyMD’s services include chronic pain evaluation and management, medication-assisted treatment for opioid-use disorder, behavioral health care and related primary or supportive healthcare services.